Tennessee Pharmacists’ Opinions on Barriers and Facilitators to Initiate PrEP: A Qualitative Study
Pre-exposure prophylaxis (PrEP) is recommended to prevent the transmission of the human immunodeficiency virus (HIV). Although an effective treatment, the uptake in the United States remains low. Pharmacists are well-positioned to initiate the conversation with patients about PrEP, but few studies e...
Gespeichert in:
| Veröffentlicht in: | International journal of environmental research and public health 2022-07, Vol.19 (14), p.8431 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 14 |
| container_start_page | 8431 |
| container_title | International journal of environmental research and public health |
| container_volume | 19 |
| creator | Cernasev, Alina Walker, Crystal Kerr, Caylin Barenie, Rachel E. Armstrong, Drew Golden, Jay |
| description | Pre-exposure prophylaxis (PrEP) is recommended to prevent the transmission of the human immunodeficiency virus (HIV). Although an effective treatment, the uptake in the United States remains low. Pharmacists are well-positioned to initiate the conversation with patients about PrEP, but few studies exist exploring their unique roles. The objective of this study was to characterize Tennessee pharmacists’ perceptions about access to PrEP. A qualitative study was used to gather the data that consisted of virtual Focus Groups over four months in 2021 from practicing Tennessee pharmacists. Emails were sent to all Tennessee licensed pharmacists to recruit them to participate in the study. Recruitment continued until Thematic Saturation was obtained. The corpus of data was audio-recorded, transcribed, and analyzed by the research team. Thematic Analysis revealed two themes: (1) Barriers to accessing PrEP; (2) Potential solutions to address barriers identified. These findings highlighted barriers and identified solutions to improve access to PrEP in Tennessee; additional financial assistance programs and marketing programs targeting patients and providers are needed to enhance PrEP access. |
| doi_str_mv | 10.3390/ijerph19148431 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9323707</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2695287995</sourcerecordid><originalsourceid>FETCH-LOGICAL-c395t-247caa4e14b56bf6578c188201c596fb2b05a50041d63c6c621a269e4aae41cb3</originalsourceid><addsrcrecordid>eNpdkU1rVTEQhoMo9kO3rgNu3Nya75O4ENrSaqHQinUd5uTM9eZybnJNcgrd-Tf8e_0lntpSWlczzPvwzgwvIe84O5DSsY9xjWW74o4rqyR_QXa5MWyhDOMvn_Q7ZK_WNWPSKuNekx2prTXCil0yXGFKWCsivVxB2UCItdXb33_oxTammFOlOdEjKCViqRTSQE9nZowNWp4HLdOzFFuENhuUk8tP9JB-m-CfHq-Rfm_TcPOGvFrCWPHtQ90nP05Pro6_Ls4vvpwdH54vgnS6LYTqAoBCrnpt-qXRnQ3cWsF40M4se9EzDZoxxQcjgwlGcBDGoQJAxUMv98nne9_t1G9wCJhagdFvS9xAufEZon-upLjyP_O1d1LIjnWzwYcHg5J_TVib38QacBwhYZ6qn7dpYTvn9Iy-_w9d56mk-b07SjEuOsFn6uCeCiXXWnD5eAxn_i5A_zxA-RcIVI94</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2694012721</pqid></control><display><type>article</type><title>Tennessee Pharmacists’ Opinions on Barriers and Facilitators to Initiate PrEP: A Qualitative Study</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>PubMed Central Open Access</source><creator>Cernasev, Alina ; Walker, Crystal ; Kerr, Caylin ; Barenie, Rachel E. ; Armstrong, Drew ; Golden, Jay</creator><creatorcontrib>Cernasev, Alina ; Walker, Crystal ; Kerr, Caylin ; Barenie, Rachel E. ; Armstrong, Drew ; Golden, Jay</creatorcontrib><description>Pre-exposure prophylaxis (PrEP) is recommended to prevent the transmission of the human immunodeficiency virus (HIV). Although an effective treatment, the uptake in the United States remains low. Pharmacists are well-positioned to initiate the conversation with patients about PrEP, but few studies exist exploring their unique roles. The objective of this study was to characterize Tennessee pharmacists’ perceptions about access to PrEP. A qualitative study was used to gather the data that consisted of virtual Focus Groups over four months in 2021 from practicing Tennessee pharmacists. Emails were sent to all Tennessee licensed pharmacists to recruit them to participate in the study. Recruitment continued until Thematic Saturation was obtained. The corpus of data was audio-recorded, transcribed, and analyzed by the research team. Thematic Analysis revealed two themes: (1) Barriers to accessing PrEP; (2) Potential solutions to address barriers identified. These findings highlighted barriers and identified solutions to improve access to PrEP in Tennessee; additional financial assistance programs and marketing programs targeting patients and providers are needed to enhance PrEP access.</description><identifier>ISSN: 1660-4601</identifier><identifier>ISSN: 1661-7827</identifier><identifier>EISSN: 1660-4601</identifier><identifier>DOI: 10.3390/ijerph19148431</identifier><identifier>PMID: 35886282</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Ambulatory care ; Antiretroviral drugs ; Audio data ; Codes ; Disease prevention ; Drug stores ; Focus groups ; Hispanic Americans ; HIV ; Human immunodeficiency virus ; Licenses ; Patients ; Pharmacists ; Prophylaxis ; Qualitative analysis ; Qualitative research ; Researchers</subject><ispartof>International journal of environmental research and public health, 2022-07, Vol.19 (14), p.8431</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c395t-247caa4e14b56bf6578c188201c596fb2b05a50041d63c6c621a269e4aae41cb3</citedby><cites>FETCH-LOGICAL-c395t-247caa4e14b56bf6578c188201c596fb2b05a50041d63c6c621a269e4aae41cb3</cites><orcidid>0000-0002-3094-1667</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323707/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323707/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Cernasev, Alina</creatorcontrib><creatorcontrib>Walker, Crystal</creatorcontrib><creatorcontrib>Kerr, Caylin</creatorcontrib><creatorcontrib>Barenie, Rachel E.</creatorcontrib><creatorcontrib>Armstrong, Drew</creatorcontrib><creatorcontrib>Golden, Jay</creatorcontrib><title>Tennessee Pharmacists’ Opinions on Barriers and Facilitators to Initiate PrEP: A Qualitative Study</title><title>International journal of environmental research and public health</title><description>Pre-exposure prophylaxis (PrEP) is recommended to prevent the transmission of the human immunodeficiency virus (HIV). Although an effective treatment, the uptake in the United States remains low. Pharmacists are well-positioned to initiate the conversation with patients about PrEP, but few studies exist exploring their unique roles. The objective of this study was to characterize Tennessee pharmacists’ perceptions about access to PrEP. A qualitative study was used to gather the data that consisted of virtual Focus Groups over four months in 2021 from practicing Tennessee pharmacists. Emails were sent to all Tennessee licensed pharmacists to recruit them to participate in the study. Recruitment continued until Thematic Saturation was obtained. The corpus of data was audio-recorded, transcribed, and analyzed by the research team. Thematic Analysis revealed two themes: (1) Barriers to accessing PrEP; (2) Potential solutions to address barriers identified. These findings highlighted barriers and identified solutions to improve access to PrEP in Tennessee; additional financial assistance programs and marketing programs targeting patients and providers are needed to enhance PrEP access.</description><subject>Ambulatory care</subject><subject>Antiretroviral drugs</subject><subject>Audio data</subject><subject>Codes</subject><subject>Disease prevention</subject><subject>Drug stores</subject><subject>Focus groups</subject><subject>Hispanic Americans</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Licenses</subject><subject>Patients</subject><subject>Pharmacists</subject><subject>Prophylaxis</subject><subject>Qualitative analysis</subject><subject>Qualitative research</subject><subject>Researchers</subject><issn>1660-4601</issn><issn>1661-7827</issn><issn>1660-4601</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkU1rVTEQhoMo9kO3rgNu3Nya75O4ENrSaqHQinUd5uTM9eZybnJNcgrd-Tf8e_0lntpSWlczzPvwzgwvIe84O5DSsY9xjWW74o4rqyR_QXa5MWyhDOMvn_Q7ZK_WNWPSKuNekx2prTXCil0yXGFKWCsivVxB2UCItdXb33_oxTammFOlOdEjKCViqRTSQE9nZowNWp4HLdOzFFuENhuUk8tP9JB-m-CfHq-Rfm_TcPOGvFrCWPHtQ90nP05Pro6_Ls4vvpwdH54vgnS6LYTqAoBCrnpt-qXRnQ3cWsF40M4se9EzDZoxxQcjgwlGcBDGoQJAxUMv98nne9_t1G9wCJhagdFvS9xAufEZon-upLjyP_O1d1LIjnWzwYcHg5J_TVib38QacBwhYZ6qn7dpYTvn9Iy-_w9d56mk-b07SjEuOsFn6uCeCiXXWnD5eAxn_i5A_zxA-RcIVI94</recordid><startdate>20220710</startdate><enddate>20220710</enddate><creator>Cernasev, Alina</creator><creator>Walker, Crystal</creator><creator>Kerr, Caylin</creator><creator>Barenie, Rachel E.</creator><creator>Armstrong, Drew</creator><creator>Golden, Jay</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3094-1667</orcidid></search><sort><creationdate>20220710</creationdate><title>Tennessee Pharmacists’ Opinions on Barriers and Facilitators to Initiate PrEP: A Qualitative Study</title><author>Cernasev, Alina ; Walker, Crystal ; Kerr, Caylin ; Barenie, Rachel E. ; Armstrong, Drew ; Golden, Jay</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c395t-247caa4e14b56bf6578c188201c596fb2b05a50041d63c6c621a269e4aae41cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Ambulatory care</topic><topic>Antiretroviral drugs</topic><topic>Audio data</topic><topic>Codes</topic><topic>Disease prevention</topic><topic>Drug stores</topic><topic>Focus groups</topic><topic>Hispanic Americans</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Licenses</topic><topic>Patients</topic><topic>Pharmacists</topic><topic>Prophylaxis</topic><topic>Qualitative analysis</topic><topic>Qualitative research</topic><topic>Researchers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cernasev, Alina</creatorcontrib><creatorcontrib>Walker, Crystal</creatorcontrib><creatorcontrib>Kerr, Caylin</creatorcontrib><creatorcontrib>Barenie, Rachel E.</creatorcontrib><creatorcontrib>Armstrong, Drew</creatorcontrib><creatorcontrib>Golden, Jay</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of environmental research and public health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cernasev, Alina</au><au>Walker, Crystal</au><au>Kerr, Caylin</au><au>Barenie, Rachel E.</au><au>Armstrong, Drew</au><au>Golden, Jay</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tennessee Pharmacists’ Opinions on Barriers and Facilitators to Initiate PrEP: A Qualitative Study</atitle><jtitle>International journal of environmental research and public health</jtitle><date>2022-07-10</date><risdate>2022</risdate><volume>19</volume><issue>14</issue><spage>8431</spage><pages>8431-</pages><issn>1660-4601</issn><issn>1661-7827</issn><eissn>1660-4601</eissn><abstract>Pre-exposure prophylaxis (PrEP) is recommended to prevent the transmission of the human immunodeficiency virus (HIV). Although an effective treatment, the uptake in the United States remains low. Pharmacists are well-positioned to initiate the conversation with patients about PrEP, but few studies exist exploring their unique roles. The objective of this study was to characterize Tennessee pharmacists’ perceptions about access to PrEP. A qualitative study was used to gather the data that consisted of virtual Focus Groups over four months in 2021 from practicing Tennessee pharmacists. Emails were sent to all Tennessee licensed pharmacists to recruit them to participate in the study. Recruitment continued until Thematic Saturation was obtained. The corpus of data was audio-recorded, transcribed, and analyzed by the research team. Thematic Analysis revealed two themes: (1) Barriers to accessing PrEP; (2) Potential solutions to address barriers identified. These findings highlighted barriers and identified solutions to improve access to PrEP in Tennessee; additional financial assistance programs and marketing programs targeting patients and providers are needed to enhance PrEP access.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>35886282</pmid><doi>10.3390/ijerph19148431</doi><orcidid>https://orcid.org/0000-0002-3094-1667</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1660-4601 |
| ispartof | International journal of environmental research and public health, 2022-07, Vol.19 (14), p.8431 |
| issn | 1660-4601 1661-7827 1660-4601 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9323707 |
| source | MDPI - Multidisciplinary Digital Publishing Institute; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; PubMed Central Open Access |
| subjects | Ambulatory care Antiretroviral drugs Audio data Codes Disease prevention Drug stores Focus groups Hispanic Americans HIV Human immunodeficiency virus Licenses Patients Pharmacists Prophylaxis Qualitative analysis Qualitative research Researchers |
| title | Tennessee Pharmacists’ Opinions on Barriers and Facilitators to Initiate PrEP: A Qualitative Study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T21%3A15%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tennessee%20Pharmacists%E2%80%99%20Opinions%20on%20Barriers%20and%20Facilitators%20to%20Initiate%20PrEP:%20A%20Qualitative%20Study&rft.jtitle=International%20journal%20of%20environmental%20research%20and%20public%20health&rft.au=Cernasev,%20Alina&rft.date=2022-07-10&rft.volume=19&rft.issue=14&rft.spage=8431&rft.pages=8431-&rft.issn=1660-4601&rft.eissn=1660-4601&rft_id=info:doi/10.3390/ijerph19148431&rft_dat=%3Cproquest_pubme%3E2695287995%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2694012721&rft_id=info:pmid/35886282&rfr_iscdi=true |